FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1097-1098 April 4, 2002 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

To the Editor: Since a 1945 church decision, Jehovah's Witnesses have refused blood transfusions, even in cases of life-threatening hemorrhage. As a result, physicians need to be aware of alternative therapeutic options for Jehovah's Witnesses.

A 44-year-old Jehovah's Witness was injured in a motor vehicle collision. She sustained a temporal subarachnoid hemorrhage; an orbital tripod fracture; facial lacerations, which were closed urgently for hemostasis; bilateral pulmonary contusions; three rib fractures; and a grade 1 splenic laceration. She was hemodynamically stable, and the initial hemoglobin level was 11 g per deciliter. When the hemoglobin level fell to 5.4 g per deciliter, . . . [Full Text of this Article]

References

Related Letters:

Combined Blood Substitute and Erythropoietin Therapy in a Severely Injured Jehovah's Witness
Hardy J.-F., Bélisle S., Van der Linden P., Cothren C., Moore E. E., Johnson J. L.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:696-697, Aug 29, 2002. Correspondence

This article has been cited by other articles:

• Schalte, G., Janz, H., Busse, J., Jovanovic, V., Rossaint, R., Kuhlen, R. (2005). Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. Br J Anaesth 94: 442-444 [Abstract] [Full Text]  
• McKechnie, R. S., Smith, D., Montoye, C., Kline-Rogers, E., O'Donnell, M. J., DeFranco, A. C., Meengs, W. L., McNamara, R., McGinnity, J. G., Patel, K., Share, D., Riba, A., Khanal, S., Moscucci, M., for the Blue Cross Blue Shield of Michigan Cardiov, (2004). Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary Intervention. Circulation 110: 271-277 [Abstract] [Full Text]  
• Hashem, B., Dillard, T. A. (2004). A 44-Year-Old Jehovah's Witness With Life-Threatening Anemia From Uterine Bleeding. Chest 125: 1151-1154 [Full Text]  
• Bagshaw, S. M., Ghali, W. A. (2003). Erythropoietin and Transfusions Among Critically Ill Patients. JAMA 289: 1511-1511 [Full Text]  
• Hardy, J.-F., Belisle, S., Van der Linden, P., Cothren, C., Moore, E. E., Johnson, J. L. (2002). Combined Blood Substitute and Erythropoietin Therapy in a Severely Injured Jehovah's Witness. NEJM 347: 696-697 [Full Text]  
• Knuti, K. A., Amrein, P. C., Chabner, B. A., Lynch, T. J. Jr., Penson, R. T. (2002). Faith, Identity, and Leukemia: When Blood Products are Not an Option. The Oncologist 7: 371-380 [Abstract] [Full Text]